Pregabalin capsule and preparation method thereof

A pregabalin and capsule technology, applied in the field of medicine, can solve the problems of poor compressibility of pregabalin, difficulty in forming granules to improve fluidity, etc., and achieve the effects of stable dissolution behavior without change and improving dissolution rate.

Inactive Publication Date: 2019-12-27
HANGZHOU BIO SINCERITY PHARMA TECH CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, wet granulation (especially wet granulation with lactose as filler) is not suitable for the preparation of pregabalin capsules

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pregabalin capsule and preparation method thereof
  • Pregabalin capsule and preparation method thereof
  • Pregabalin capsule and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1~3

[0020] Table 1: Prescription Table of Embodiments 1 to 3

[0021]

[0022] Choose pregabalin particle size distribution: D 90 100~250μm, D 50 35~75μm; choose the particle size distribution of silicified microcrystalline cellulose: D 90 200-350 μm; D 50 It is 90-130 μm. The above unit dose composition is placed in a gelatin hollow capsule.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pregabalin capsule and a preparation method thereof. The content is composed of pregabalin and silicified microcrystalline cellulose, wherein the silicified microcrystallinecellulose is prepared by blending microcrystalline cellulose and micro-powder silica gel in water and performing drying. In the pregabalin capsule, a weight percentage of pregabalin is 25-75%, D90 is100-250 [mu]m, and D50 is 35-75 [mu]m; and D90 of the excipient silicified microcrystalline cellulose is 200-350 [mu]m, and D50 is 90-130 [mu]m. The production process is simple, the product is stable, and the pregabalin capsule is suitable for large-scale industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pregabalin capsule and a preparation method thereof. Background technique [0002] Pregabalin is a new type of antiepileptic drug. Its molecular structure has γ-aminobutyric acid structure, so it has anticonvulsant effect. [0003] Pregabalin is a class I drug in the BCS classification system. Pregabalin reaches its peak concentration after 1.5 hours of oral administration, and its relative bioavailability is ≥90%, and C max And AUC has a linear relationship with the dose, it is not combined with plasma protein in vivo, and has almost no metabolism. [0004] Pregabalin was successfully developed by Pfizer Europe MA EEIG. It was first approved for marketing by the European Medicines Agency (EMA) on July 6, 2004. 100mg, 150mg, 200mg, 225mg, 300mg), oral liquid (specification: 20mg / ml). [0005] The EMA review report shows that the pregabalin capsules (trade name ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/48A61K31/197A61K47/38A61P25/08
CPCA61K31/197A61K9/4866A61P25/08
Inventor 陈晓萍李柳洋邹永华陆勤霞巴文静潘晨
Owner HANGZHOU BIO SINCERITY PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products